AMSACRINE - A REVIEW

被引:47
作者
CASSILETH, PA
GALE, RP
机构
[1] UNIV PENN,CTR CANC,PHILADELPHIA,PA 19104
[2] UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV HEMATOL & ONCOL,LOS ANGELES,CA 90024
关键词
D O I
10.1016/0145-2126(86)90331-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1257 / 1265
页数:9
相关论文
共 112 条
[1]  
AHMANN FR, 1983, CANCER TREAT REP, V67, P697
[2]   THE TREATMENT OF MELANOMA WITH M-AMSA - A CANCER AND LEUKEMIA GROUP-B PHASE-II STUDY [J].
AMREIN, PC ;
POULIN, RF ;
COLEMAN, M ;
RICHARDS, F ;
WEIL, M ;
KENNEDY, BJ ;
CAREY, RW ;
GREEN, MR ;
HOLLAND, JF ;
WEINBERG, V ;
RAFLA, S .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (03) :269-271
[3]  
AMREIN PC, 1982, CANCER TREAT REP, V66, P1211
[4]  
AMREIN PC, 1983, CANCER TREAT REP, V67, P1043
[5]  
ARLIN Z, 1984, BLOOD, V63, P211
[6]  
ARLIN ZA, 1981, CANCER CLIN TRIALS, V4, P317
[7]  
ARLIN ZA, 1980, CANCER RES, V40, P3304
[8]  
ARLIN ZA, 1983, AMSACRINE CURRENT PE, P77
[9]   PHASE-II STUDY OF META-AMSA IN ADVANCED MALIGNANT-MELANOMA [J].
ARSENEAU, JC ;
WOLTER, JM ;
PROBERT, JC ;
KUPERMINC, M .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (04) :433-436
[10]  
BAJETTA E, 1985, CANCER TREAT REP, V69, P965